Loading...
Increased exposure of norethindrone in HIV+ women treated with ritonavir boosted atazanavir therapy
OBJECTIVE: Pharmacokinetics of norethindrone in combination oral contraceptive regimen are well described among HIV+ women treated with ritonavir boosted protease inhibitor therapies; however such characterization is lacking in women using progestin-only contraception. Our objective is to characteri...
Na minha lista:
| Udgivet i: | Contraception |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4268426/ https://ncbi.nlm.nih.gov/pubmed/25245190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.contraception.2014.08.009 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|